News
News
Spinal Muscular Atrophy: A Rare but Treatable Disease of the Nervous System

Adelphi Values Interview Study – Physical Ability: What is important to you?

Resonate 2023, what a weekend!

Research into the views of the SMA Community towards newborn screening for SMA in the UK

Biogen Provide Update on Phase 4 RESPOND trial of Spinraza

5-Year Results from the Nurture Spinraza Trial Published

Scholar Rock Provide Update on Phase 2 TOPAZ trial of Apitegromab

We are excited to share with you our brand refresh and new website!
Say hello to Gary!
